Every Form 4 that Mobix Labs, Inc. (MOBX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MOBX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MOBX filings page.
MOBIX LABS, INC (MOBX) director and executive officer Keyvan Samini reported a conversion of 12,500 shares of Class B Common Stock held indirectly through the KSSF Trust into 12,500 shares of Class A Common Stock on a one-for-one basis, with no consideration paid, pursuant to the company’s certificate of incorporation. After the conversion, the KSSF Trust held 29,614 Class A shares, and Mr. Samini also reported 155,053 Class A shares held directly, plus additional indirect Class A holdings through other trusts. He further reported fully vested options to acquire 32,353 Class A shares at $1.70 per share, expiring on August 10, 2030. For trust-held shares, he disclaims beneficial ownership except to the extent of his pecuniary interest.
MOBIX LABS, INC (symbol: MOBX) is the issuer of record for a Form 4 filing submitted to the SEC.
MOBIX LABS, INC (MOBX) director Frederick C. Goerner reported a conversion of 21,739 shares of Class B Common Stock into 21,739 shares of Class A Common Stock on August 21, 2026. The conversion was on a one-for-one basis pursuant to the company’s Certificate of Incorporation, and no consideration was paid.
Following the conversion, Goerner directly holds 207,456 shares of Class A Common Stock. He also holds fully vested options to acquire additional Class A shares, including options over 2,000 shares at $41.80 per share expiring August 10, 2030 and options over 13,341 shares at $68.40 per share expiring April 4, 2032.
Mobix Labs, Inc. director and Chief Executive Officer Philip Sansone reported selling 9,301 shares of Class A common stock on July 16, 2026 at a weighted average price of $1.8669 per share, leaving 166,130 shares held directly. The sale was made under an irrevocable “sell to cover” election solely to satisfy tax withholding from restricted stock units vesting that day and is described as non-discretionary.
MOBIX LABS, INC director Bill Carpou reported an equity compensation grant and his outstanding option holdings. He received 13,660 shares of Class A Common Stock on June 30, 2026 at a price of $0.00 per share, classified as a grant or award, bringing his direct holdings to 67,282 shares after the transaction. Footnotes state these Restricted Stock Units were granted on June 30, 2026 and vested on July 1, 2026, meaning they became fully earned one day after grant.
The filing also lists two fully vested stock option positions. One option covers 13,341 underlying Class A Common shares at an exercise price of $68.40 per share, expiring on April 4, 2032. Another option covers 2,000 underlying shares at an exercise price of $41.80, expiring on August 10, 2030. No open-market buys or sells were reported; the activity reflects compensation and existing derivative holdings.
MOBIX LABS, INC director and 10% owner James J. Peterson received an equity award in the form of Class A Common Stock. He acquired 13,660 shares of Class A Common Stock on a grant or award basis at a stated price of $0.00 per share, tied to Restricted Stock Units granted on June 30, 2026 that vested on July 1, 2026.
Following this award, he directly holds 339,122 shares of Class A Common Stock. He also has derivative positions linked to Class A shares: 144,927 underlying shares through Class B Common Stock that is convertible into Class A, plus fully vested options covering 13,341 shares at an exercise price of $68.40 per share expiring on April 4, 2032, and 2,000 shares at $41.80 per share expiring on August 10, 2030.
LONG MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
MOBIX LABS, INC director Michael J. Long received an equity award in the form of restricted stock units. The Form 4 shows a grant of 13,660 shares of Class A common stock at no cash cost to him, increasing his directly held position to 138,592 shares.
The footnote explains these Restricted Stock Units were granted on June 30, 2026 and vested on July 1, 2026, indicating this was a compensation-related award rather than an open-market purchase or sale.
Goerner Frederick C reported acquisition or exercise transactions in this Form 4 filing.
Mobix Labs director Frederick C. Goerner received an equity award of 13,660 shares of Class A Common Stock on June 30, 2026, at a price of $0.0000 per share. These shares relate to Restricted Stock Units granted on June 30, 2026 that vested on July 1, 2026. Following this grant, he directly holds 185,717 shares of Class A Common Stock. He also holds Class B Common Stock convertible into 21,739 Class A shares at his option, plus fully vested options to buy 13,341 Class A shares at $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030.
Mobix Labs director Kurt Busch reported a new equity grant. He received 13,660 shares of Class A Common Stock as a grant or award at a price of $0.00 per share, increasing his direct holdings to 74,621 shares. Footnotes state these Restricted Stock Units were granted on June 30, 2026 and vested on July 1, 2026.
He also holds fully vested options to buy 13,341 shares at an exercise price of $68.40 per share expiring on April 4, 2032, and options to buy 2,000 shares at $41.80 per share expiring on August 10, 2030.
MOBIX LABS director David J. Aldrich reported a stock award of 13,660 Class A common shares as compensation. These shares were granted on June 30, 2026 at no cost and arose from Restricted Stock Units that vested on July 1, 2026.
After this grant, Aldrich directly owned 66,353 shares of Class A common stock. He also held fully vested options over 13,341 shares with a $68.40 exercise price expiring April 4, 2032, and options over 2,000 shares with a $41.80 exercise price expiring August 10, 2030.
MOBIX Labs President, CFO and Director Keyvan Samini reported selling Class A Common Stock in open-market transactions. On June 12, 2026, he sold 112,110 shares at a weighted average price of $1.9807 per share. On June 11, 2026, he sold an additional 3 shares at a weighted average price of $2.1367 per share.
After these sales, Samini directly holds 155,053 Class A shares. The filing also shows indirect holdings in several trusts and remaining equity exposure through fully vested options to buy 32,353 Class A shares at $1.70 per share and Class B shares convertible into 12,500 Class A shares.
LONG MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
Mobix Labs, Inc. director Michael J. Long reported equity awards in the company’s Class A common stock. He received 14,805 shares on February 25, 2026 and an additional 5,000 shares on March 30, 2026, both recorded as grants or awards at a price of $0.00 per share.
After these transactions, Long directly owned 124,932 shares of Class A common stock. A footnote explains that an earlier grant of Restricted Stock Units was made on February 25, 2026 and vested on April 1, 2026, and that his beneficial ownership was adjusted for rounding following a 1-for-10 reverse stock split effective April 6, 2026.
Mobix Labs director Kurt Busch reported new equity awards in Mobix Labs, Inc. Class A Common Stock. He received 14,805 shares on February 25, 2026 and 5,000 shares on March 30, 2026 as grant or award acquisitions at no stated purchase price.
After these awards, Busch directly owns 60,961 Class A shares. He also holds fully vested options to buy 13,341 shares at $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030. Reported holdings reflect a 1-for-10 reverse stock split on April 6, 2026.
MOBIX Labs director and 10% owner James J. Peterson reported stock awards and updated holdings in the company’s shares. He received Class A Common Stock awards of 14,805 shares on February 25, 2026 and 5,000 shares on March 30, 2026, both at $0.00 per share as grants.
Following the latest award, he directly holds 325,462 shares of Class A Common Stock. Footnotes state these Restricted Stock Units were granted on February 25, 2026 and vested on April 1, 2026, and that his beneficial ownership figures were adjusted for a 1-for-10 reverse stock split effective April 6, 2026. He also holds Class B Common Stock convertible into 144,927 Class A shares at the holder’s option, plus fully vested options over 13,341 Class A shares at an exercise price of $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030.
MOBIX LABS, INC director Frederick C. Goerner reported stock-based compensation awards rather than open‑market trades. He received grants of 14,805 and 5,000 shares of Class A Common Stock at a price of $0.00 per share, described as restricted stock units that were granted on February 25, 2026 and vested on April 1, 2026.
After these awards, he directly owns 172,057 shares of Class A Common Stock. He also holds Class B Common Stock convertible into 21,739 Class A shares at an exercise price of $0.00, plus fully vested options covering 13,341 shares at $68.40 per share and 2,000 shares at $41.80 per share.
ALDRICH DAVID J reported acquisition or exercise transactions in this Form 4 filing.
Mobix Labs director David J. Aldrich reported equity awards in MOBX stock. He received grants of 14,805 shares of Class A Common Stock on February 25, 2026 and 5,000 shares on March 30, 2026, both at a stated price of $0.00 per share, reflecting compensation rather than open‑market purchases. Following these awards, he directly holds 52,693 Class A shares. Footnotes state the February 25, 2026 award consisted of Restricted Stock Units that vested on April 1, 2026, and that his beneficial ownership has been adjusted for a 1‑for‑10 reverse stock split effective April 6, 2026. He also holds fully vested options to buy 13,341 shares at $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030.
MOBIX LABS, INC director Bill Carpou reported new equity awards in the form of Class A Common Stock. On February 25, 2026 and March 30, 2026, he received stock awards of 14,805 and 5,000 shares, respectively, at $0.00 per share as grant/award acquisitions. Footnotes state these awards relate to Restricted Stock Units granted on February 25, 2026 that vested on April 1, 2026.
Following these awards, Carpou directly owns 53,622 shares of Class A Common Stock. He also holds fully vested options to buy 13,341 shares at an exercise price of $68.40 per share expiring on April 4, 2032, and options for 2,000 shares at $41.80 per share expiring on August 10, 2030. A footnote notes his beneficial ownership share count was adjusted for a 1-for-10 reverse stock split effected on April 6, 2026.
MOBIX Labs, Inc. director and CEO Philip Sansone reported an open-market sale of 9,541 shares of Class A Common Stock. The shares were sold at a weighted average price of $2.3544 per share to cover tax liabilities from restricted stock units that vested on April 30, 2026, under an irrevocable sell-to-cover election and not as discretionary trades.
After these transactions, Sansone directly holds 175,431 shares of Class A Common Stock. The company effected a 1-to-10 reverse stock split on April 6, 2026, which reduced his direct holdings.
Mobix Labs CEO Philip Sansone filed a Form 4 showing an automatic tax-related sale of shares. On February 2, 2026, Sansone sold 87,025 shares of Mobix Labs Class A common stock at a weighted-average price of $0.188 per share in a transaction coded as a sale.
According to the disclosure, the shares were sold solely to cover taxes arising from restricted stock units that vested on January 31, 2026, under a pre‑set “sell to cover” election, meaning the trades were not discretionary. After this transaction, Sansone directly beneficially owned 1,848,816 shares of Mobix Labs.
Mobix Labs, Inc. insider Samini Keyvan reported equity award activity and a related share sale. On December 21, 2025, 333,333 Restricted Stock Units vested and converted into 333,333 shares of Class A Common Stock at a stated price of $0.00 per share. On January 5, 2026, Keyvan sold 211,672 shares of Class A Common Stock at a weighted average price of $0.3243 per share, with prices ranging from $0.32 to $0.328 per share. According to the disclosure, these shares were sold solely to satisfy tax withholding obligations from the RSU vesting under a pre-arranged sell-to-cover election and are not discretionary trades. Following these transactions, Keyvan directly beneficially owns 2,671,661 shares of Class A Common Stock, with additional indirect holdings through family trusts, and holds fully vested options covering 323,529 Class A shares.
Mobix Labs, Inc. (MOBX) reported an insider transaction by its Chief Executive Officer and director. On 11/21/2025, the reporting person sold 100,044 shares of Class A common stock at a weighted average price of $0.412 per share. The filing explains that these shares were sold to cover withholding tax obligations tied to the vesting of restricted stock units.
After this transaction, the reporting person beneficially owns 1,935,841 shares of Class A common stock, held directly. The sale prices ranged from $0.4001 to $0.4151 per share, and detailed pricing information is available upon request from the reporting person.
Mobix Labs, Inc. (MOBX) reported an insider transaction by its Chief Technology Officer on a Form 4. On 11/21/2025, the CTO sold 22,470 shares of Class A common stock at a weighted average price of $0.4069 per share. The filing explains that these shares were sold to cover withholding tax obligations related to the vesting of restricted stock units.
After this transaction, the CTO beneficially owns 106,523 shares of Class A common stock. The filing also lists fully vested stock options giving the right to buy 16,112 shares and 183 shares of Class A common stock at an exercise price of $6.84 per share, with an expiration date of 04/04/2032.
Mobix Labs, Inc. (MOBX) reported an amended insider filing (Form 4/A) to correct the officer’s reported holdings. The amendment updates the directly held Class A common stock beneficially owned to 2,550,000 shares as of the prior filing date referenced.
The filing also lists indirect derivative holdings through the KSSF Trust tied to 125,000 shares of Class A. The Class B common stock is convertible into Class A at the holder’s option and will convert automatically upon a non‑permitted transfer or on the first trading day after the seventh anniversary of the December 21, 2023 closing date. The reporting person serves as President, CFO & Director.
Mobix Labs, Inc. (MOBX) insider filing: The Chief Executive Officer and Director reported an award of 1,000,000 Restricted Stock Units on September 19, 2025 at a price of $0.00. The RSUs are scheduled to vest in four equal 25% installments on January 1, 2027, April 1, 2027, July 1, 2027, and October 1, 2027. After this grant, the reporting person beneficially owns 2,035,885 shares of Class A common stock, held directly.
Bill Carpou, a director of MOBIX LABS, INC. (MOBX), reported equity changes dated 09/23/2025. The filing shows a grant of 46,855 Restricted Stock Units (RSUs) to the reporting person, increasing his direct beneficial ownership to 299,022 Class A common shares after the transaction. The report also discloses two fully vested stock options: one with an exercise price of $4.18 covering 20,000 shares (expiring 08/10/2030) and another with an exercise price of $6.84 covering 133,416 shares (expiring 04/04/2032). The form was signed on behalf of the reporting person by an attorney-in-fact on 09/25/2025.
Frederick C. Goerner, a director of Mobix Labs, Inc. (MOBX), reported multiple equity awards and holdings. On 09/23/2025 he was granted 46,855 Restricted Stock Units (RSUs) with a reported price of $0, bringing his reported beneficial ownership to 1,483,380 shares of Class A Common Stock (direct). The filing also shows fully vested, exercisable options to purchase 20,000 shares at $4.18 and 133,416 shares at $6.84. Additionally, the report lists 217,391 shares of Class B Common Stock convertible into Class A Common Stock; conversion occurs at the Reporting Person's option and will be automatic upon certain transfers or upon the first trading day after the seventh anniversary of the Closing Date. The Form 4 was signed by an attorney-in-fact on 09/25/2025.
Kurt Busch, a director of Mobix Labs, Inc. (MOBX), reported awards and existing holdings on a Form 4 dated with transactions on 09/23/2025. The filing shows 46,855 restricted stock units (RSUs) were granted to Mr. Busch on 09/23/2025, increasing his beneficial ownership to 372,429 shares of Class A common stock.
The report also lists two fully vested, exercisable stock options held directly by Mr. Busch: an option to buy 20,000 shares at an exercise price of $4.18 (expiration 08/10/2030) and an option to buy 133,416 shares at $6.84 (expiration 04/04/2032). The Form 4 was signed by an attorney-in-fact, Terri Aprati, on 09/25/2025.
Mobix Labs insider report: Director David J. Aldrich received 46,855 Restricted Stock Units on September 23, 2025 that will vest on October 1, 2025, and acquired the RSUs at no cash cost. Following that grant, he beneficially owns 289,744 shares of Class A common stock.
Derivative holdings: The filing discloses two fully vested, exercisable stock options: 20,000 options with a $4.18 exercise price (expiring 08/10/2030) and 133,416 options with a $6.84 exercise price (expiring 04/04/2032). The form was signed by an attorney-in-fact on September 25, 2025.